Invention Grant
- Patent Title: Pentose derivatives as anti-hyperglycemic drugs
- Patent Title (中): 戊糖衍生物作为抗高血糖药物
-
Application No.: US11109907Application Date: 2005-04-19
-
Publication No.: US07812142B2Publication Date: 2010-10-12
- Inventor: Shlomo Sasson , Erol Cerasi , Arie Gruzman , Joshua Katzhendler
- Applicant: Shlomo Sasson , Erol Cerasi , Arie Gruzman , Joshua Katzhendler
- Applicant Address: IL Jerusalem IL Jerusalem
- Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem,Hadasit Medical Research Services and Development Ltd.
- Current Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem,Hadasit Medical Research Services and Development Ltd.
- Current Assignee Address: IL Jerusalem IL Jerusalem
- Agency: Winston & Strawn LLP
- Priority: IL152397 20021021
- Main IPC: A61K31/7004
- IPC: A61K31/7004 ; A61K31/7008 ; A61K31/7028 ; C07H5/06 ; C07H5/10 ; C07H9/04 ; C07H15/04 ; C07H15/10

Abstract:
The present invention relates to pentose and pentose derivatives that are effective at increasing glucose transport in a non-insulin dependent manner, and to uses thereof for a) treating and/or preventing hyperglycemia; b) treating and/or preventing the complications of hyperglycemia; c) treating diabetes; d) increasing the rate of cellular glucose transport; e) increasing the rate of cellular glucose uptake; f) improving the ability of a subject to metabolize glucose; g) treating daily blood glucose fluctuations; h) reducing blood sugar levels; i) reducing the dosage of anti-diabetic medication needed for treatment of diabetes. The present invention further provides novel pentose derivatives having beneficial properties in terms of pharmacokinetics, to pharmaceutical compositions comprising these novel compounds and uses thereof.
Public/Granted literature
- US20050277599A1 Pentose derivatives as anti-hyperglycemic drugs Public/Granted day:2005-12-15
Information query